RxDataLab
Data Products
Primary-source biotech datasets, structured for analysts, BD teams, and the AI tools they're building.
Structured data from primary sources, documented for analysts and AI workflows. Custom scopes available on request.
FDA Exclusivity Data, Built for Analysts
Monthly database covering FDA Orange Book (NDA/ANDA) and Purple Book (BLA) exclusivity and patent data, enriched with USPTO patents, FDA drug labels, and normalized company identifiers. Includes pre-computed loss-of-exclusivity estimates across small-molecule drugs and biologics.
RxDataLab Platform
RxDataLab links SEC filings, clinical trial data, and hedge fund positioning for 500+ public biotech companies. Built for BD, investors, and strategy teams who work from primary sources.
Biotech BD & Licensing Events
Classified 8-K events directly from SEC EDGAR: licensing agreements, strategic alternatives, M&A signals, and financing activity. Tagged by deal type, linked to company identifiers. Updated 3× daily.
Biotech Specialist Hedge Fund Positions
Structured 13D/13G ownership filings and 13F institutional holdings for biotech-focused hedge funds. Covers new positions, stake reductions, and activist threshold crossings. Linked to company and trial identifiers.
Clinical Trial Change Feed
Structured daily changes to ClinicalTrials.gov: status changes, protocol amendments, endpoint modifications, and enrollment shifts across clinical trials. Filterable by condition, sponsor, intervention or more.
RxDataLab
We deliver harmonized, primary-source datasets for BD teams, investors, and the AI tools they're building.
Tell us what you're tracking. We'll scope delivery to fit your workflow.
or email [email protected]